| Financial Year |
March 31 2023 |
| Monetary Funds |
635,307,177.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
104,979,167.12 |
| Accounts Receivable |
227,948,426.50 |
| Advances to Suppliers |
3,340,021.27 |
| Other Receivables |
1,352,501.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
193,232,812.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
1,166,160,106.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
310,547,619.06 |
| Under-construction Projects |
5,777,383.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,230,193.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,289,202.03 |
| Other Non-Current Assets |
7,856,854.09 |
| Sub-Total of Non-Current Assets |
346,701,252.11 |
| Total Assets |
1,512,861,358.67 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
37,006,532.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
545,707.09 |
| Taxes Payable |
9,556,991.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,712,705.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
172,664.58 |
| Sub-Total of Current Liabilities |
56,929,696.03 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
216,284.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,496,348.30 |
| Total Liabilities |
62,426,044.33 |
| Paid-In Capital(Or Share Stock) |
323,146,360.00 |
| Capital Surplus |
496,202,753.84 |
| Surplus Reserve |
161,573,180.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
469,513,020.50 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,450,435,314.34 |
| Owner's Equity（Stockholder's Equity） |
1,450,435,314.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,512,861,358.67 |
